GLS GLS

Gelesis Stock Price

0.402199
-0.0778 (-16.21%)
Upgrade to Real-Time
Regular Market
0.402199
Volume 54,319
Bid Price
Ask Price
News -
Day High 0.47

Low
0.24

52 Week Range

High
8.24

Day Low 0.3964
Company Name Stock Ticker Symbol Market Type
Gelesis Holdings Inc GLS NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0778 -16.21% 0.402199 12:56:30
Open Price Low Price High Price Close Price Prev Close
0.47 0.3964 0.47 0.48
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
415 54,319 $ 0.4305185 $ 23,385 - 0.24 - 8.24
Last Trade Time Type Quantity Stock Price Currency
12:58:29 10 $ 0.401633 USD

Period:

Draw Mode:

Gelesis Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 29.37M 73.03M 20.07M $ 11.19M $ - -2.60 -0.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 100.00k 6.50%

more financials information »

Gelesis News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GLS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.38990.48210.28870.4261442146,9250.01233.15%
1 Month0.280.54990.240.3799013172,3060.122243.64%
3 Months1.241.29990.240.7047571158,936-0.8378-67.56%
6 Months5.105.100.241.17132,998-4.70-92.11%
1 Year7.368.240.242.89194,555-6.96-94.54%
3 Years7.368.240.242.89194,555-6.96-94.54%
5 Years7.368.240.242.89194,555-6.96-94.54%

Gelesis Description

Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.